From surgical procedure selection to multiscale imaging to use of the latest drugs, we present a list of 10 not-to-be-missed sessions at AES 2016.
Epilepsy and Seizure
November news includes potential Alzheimer treatments, FDA approval of a device to prevent recurrent stroke, & a newly typified headache disorder.
Researchers evaluated cognitive and motor development, receptive language, and memory in 214 children who had experienced febrile status epilepticus.
Although tremendous advances in research and medical ethics have been made since the mid-20th century, questions continue.
Oct. news includes an approved deep brain stimulation system for movement disorders & biomarkers that improve risk assessment in atrial fibrillation.
To investigate an association between epilepsy and autoimmune disease, researchers reviewed 25 studies, covering patients of various ages.
Our Sept. news includes a possible clinical marker and therapy target in Alzheimer disease and MS findings from an optical coherence tomography study.
Little evidence exists to guide drug choice in elderly patients with epilepsy. The KOMET study compared carbamazepine, levitiracetam, and valproate.
New research covers treating MS early, identifying those at risk for AED-induced psychosis, & selecting a drug for epilepsy patients with migraines.
Our August news includes a potential classification system for Alzheimer disease, new findings in a 3D model of TBI, and migraine treatments.